Current Grants for Dr. Ambarish Pandey
Source | Topic | Years |
---|---|---|
Ultromics | Prevalence and Prognostic Implications of an Artificial Intelligence-based Echocardiographic Tool to Diagnosis HFpEF in a Large Health System | NEW |
Ultromics | Identifying Undiagnosed HFpEF among Patients with Type 2 Diabetes using Ultromics AI HFpEF Algorithm | NEW |
NHLBI 1R21HL169708-01 | Cardiac biomarkers, intensive blood pressure treatment and risk of adverse cardiovascular outcomes in type 2 diabetes, a secondary analysis of the ACCORD BP | NEW |
American Heart Association 24HCMFLP1284773 | Hypertrophic Cardiomyopathy Federated Learning Platform | NEW |
American Heart Association 24RPGFIM1198188 | Examining the Impact of Medically Tailored Meals vs Produce Supplements Delivered Conditionally vs Not on Heart Failure | NEW |
NIH R01 MD017529 | Polypill strategy for the evidenced-based management of heart failure with reduced ejection fraction in an underserved patient population | 2022-2026 |
SC Pharmaceuticals, Inc - Investigator Initiated Study | Role of subcutaneous furosemide to augment diuresis in heart failure patients with diuretic resistance: A randomized controlled trial | 2023-2024 |
American Heart Association | Telemedicine Enabled Care Quality Improvement Among Rural Patients with Heart Failure: The Rural-HF Project Grantor | |
American Heart Association | Machine Learning-based Models with Social Determinants of Health to Improve Incident Atrial Fibrillation Prediction | |
Roche Diagnostics (investigator-initiated study) |
Cardiovascular Biomarkers and heart failure risk in Diabetes |
Previous Grants
Source | Topic | Years |
---|---|---|
Applied Therapeutics Inc. - Investigator Initiated Study | Prevalence of diabetic cardiomyopathy and its association with risk of heart failure in the community To evaluate the prevalence of diabetic cardiomyopathy and its association with incident heart failure in the pooled epidemiological cohorts and the electronic medical records-based registry of patients with type 2 DM at UT Southwestern. |
2022-2023 |
NIH R03 AG067960 | Evaluation of Racial Differences in Cardiorespiratory Fitness Decline with Aging & Underlying Biological Mechanisms | 2020-2022 |
Gilead Sciences Inc. - Gilead Research Scholars | Association Between Baseline and Longitudinal Changes in Hepatic Steatosis with Cardiac Structure, Function, and Myocardial Injury Burden in a Multi-Ethnic Cohort of Middle-Age Adults To evaluate the association of subclinical hepatic steatosis, as assessed by MRI spectroscopy, with abnormalities in cardiac structure and function, as assessed by cardiac MRI, and myocardial injury in a well-phenotyped of the Dallas Heart Study. |
2020-2022 |
Texas Health Resources - Clinical research scholarship | Novel approaches to prediction and prevention of heart failure To develop novel, EMR-based approaches to predicting risk of heart failure and implementing clinical decision support tools to increase uptake of effective approaches for heart failure prevention. |
2018-2022 |
Current Grants for Dr. Thomas Wang
Source | Topic | Years |
---|---|---|
NIH R01-DK108159 | Metabolic profiles and the risk of diabetes in Asians | 2016-2022 |
NIH R01-DK081572 | Metabolic predictors of Insulin resistance and diabetes | 2008-2026 |
Leducq Foundation Transatlantic Network of Excellence | Brown fat and cardiovascular health | |
NIH R01 MD017529 | Polypill strategy for the evidenced-based management of heart failure with reduced ejection fraction in an underserved patient population | 2022-2026 |
Previous Grants
Source | Topic | Years |
---|---|---|
R01 HL133860 | Tissue Sodium, Inflammation, and Blood Pressure in MESA | 2016-2021 |
NIH R01-HL128983 | PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction | 2016-2021 |
NIH R01-HL133870 | Aptamer Proteomics of Cardiometabolic and Renal Traits in African Americans | 2017-2021 |
NIH T32-HL007411 | Training in Cardiovascular Research | 1994-2020 |
NIH K12-HL133117 | The Vanderbilt Emergency Care Research Training Program | 2016-2020 |